Shih C.-J.TSEN-FANG TSAIHuang H.Ko W.-C.Hung C.-M.2020-10-222020-10-2220110011-9059https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051861391&doi=10.1111%2fj.1365-4632.2009.04454.x&partnerID=40&md5=bbb4f5c5f70f78d7340bdd1aa608b7eehttps://scholars.lib.ntu.edu.tw/handle/123456789/517665[SDGs]SDG3allopurinol; aged; case report; cell swelling; disease duration; disease severity; drug dose increase; dyskeratosis; epidermis hyperplasia; face; female; human; human tissue; hyperpigmentation; kyrle disease; letter; limb; maculopapular rash; papule; parakeratosis; pruritus; recurrent disease; scar; scar formation; skin biopsy; skin disease; skin nodule; treatment duration; trunk; Aged; Allopurinol; Antioxidants; Corneal Opacity; Darier Disease; Enzyme Inhibitors; Female; Humans; Xanthine OxidaseKyrle's disease successfully treated with allopurinolletter10.1111/j.1365-4632.2009.04454.x221268872-s2.0-80051861391